Home
Index Entries
Topics
Glossary
About
Contact
Topics
emergency use authorization (EUA)
Information Sources addressing Topic
21 U.S. Code § 360bbb-3 - Authorization for medical products for use in emergencies
AFTER ACTION REVIEW OF THE COVID-19 PANDEMIC: The Lessons Learned and a Path Forward
COVID-19 Contracts
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1
Emergency Use Authorization for Vaccines to Prevent COVID-19 - Guidance for Industry
Fact Sheet for Healthcare Providers Administering Vaccine (Vaccination Providers) — Emergency Use Authorization (EUA) of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease 2019 (COVID-19)
Fact Sheet for Recipients and Caregivers - Emergency Use Authorization (EUA) of the Pfizer-Biontech COVID-19 Vaccine to Prevent Coronavirus
FDA Briefing Document - Moderna COVID-19 Vaccine
FDA Briefing Document - Pfizer-BioNTech COVID-19 Vaccine
FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine
mRNA Vaccine Toxicity
Physicians Declaration II
Summary Basis for Regulatory Action
The Book on Masks
The Science Behind Vaccine Research and Testing
WHO, BioNTech/Pfizer and FDA/EMA Knew Everything at the End of 2019
Topic ID
544
© 2023 - 2024
The Covid Index
. All rights reserved.
To Top